Search
for
Sort by
Research 30 of 236
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Folliculitis decalvans associated with erlotinib
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Loose anchoring of anagen hairs and pili torti due to erlotinib
- Prevention of erlotinib-induced folliculitis with doxycycline
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Topical Application of Aprepitant Inhibits Erlotinib-induced Facial Dermatitis/Hair Loss
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Erlotinib induced acneiform eruption: A case report
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- “PRIDE” Complex
- “Arrow” sign: A rapid microscopic diagnosis of hair change associated with epidermal growth factor receptor inhibitors
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Abstract 4350: Pharmacodynamic biomarkers: Evaluation of oncology drug target engagement in human plucked scalp and beard hair